Showing results 3 to 5 of 5
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens Journal:European Journal of Haematology | 2015 | ||
2016 | |||
2019 |